2021
DOI: 10.1080/23288604.2021.1984865
|View full text |Cite
|
Sign up to set email alerts
|

Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 8 publications
0
8
0
1
Order By: Relevance
“…The included studies were conducted in six LMICs: Peru [ 35 ], Brazil [ 36 ], India [ 37 - 44 ], Kenya [ 45 ], Bosnia and Herzegovina [ 46 ], and Mexico [ 47 ]. The highest number of studies were from India (n = 9) and Brazil (n = 2), while the rest were from one country study each.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The included studies were conducted in six LMICs: Peru [ 35 ], Brazil [ 36 ], India [ 37 - 44 ], Kenya [ 45 ], Bosnia and Herzegovina [ 46 ], and Mexico [ 47 ]. The highest number of studies were from India (n = 9) and Brazil (n = 2), while the rest were from one country study each.…”
Section: Resultsmentioning
confidence: 99%
“…Most studies employed a prospective cohort [ 35 , 36 , 39 - 41 , 47 , 48 ] or cross-sectional design [ 37 , 42 , 46 ]. Two studies used a qualitative design [ 44 , 45 ] and the rest were clinical audits/review [ 38 ] and a field-based report [ 43 ]. Table 2 summarizes the included reports’ characteristics.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations